Intersect ENT prices its IPO low as biotech offerings start to wobble
July 24, 2014 at 09:02 AM EDT
Intersect ENT Inc. priced its IPO at the low range of its target Thursday, selling 5 million shares at $11 each...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.